April 10, 2024 | Vensana Capital® Portfolio News

Elucent Medical Secures Series C Funding to Advance Oncologic Surgery Innovation

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A